Prab at 12:52, 18 March 2025

2025-03-18T12:52:58Z

← Older revision		Revision as of 12:52, 18 March 2025
Line 23:		Line 23:
	{{Medicine-stub}}		{{Medicine-stub}}
	{{No image}}		{{No image}}
	~~__NOINDEX__~~

Prab: CSV import

2025-03-17T15:30:42Z

CSV import

← Older revision		Revision as of 15:30, 17 March 2025
Line 23:		Line 23:
	{{Medicine-stub}}		{{Medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T21:29:28Z

CSV import

← Older revision		Revision as of 21:29, 10 February 2025
Line 22:		Line 22:
	[[Category:Inflammation]]		[[Category:Inflammation]]
	{{Medicine-stub}}		{{Medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-22T07:17:57Z

CSV import

New page

'''Interleukin 1 beta''' ('''IL-1β''') is a pro-inflammatory [[cytokine]] that plays a crucial role in the [[immune response]], inflammation, and [[apoptosis]]. It is a part of the interleukin 1 family, which also includes IL-1α. IL-1β is produced by activated [[macrophages]], [[monocytes]], and [[dendritic cells]]. It is a key mediator in the body's response to infection, injury, and disease.

==Production and Activation==
IL-1β is synthesized as a precursor molecule (pro-IL-1β) that requires processing to become active. The conversion of pro-IL-1β to its active form is facilitated by the [[inflammasome]], a multi-protein complex that senses pathogenic microorganisms and sterile stressors. Once activated, IL-1β is secreted and exerts its effects on various target cells by binding to the interleukin-1 receptor (IL-1R), initiating a cascade of downstream signaling pathways.

==Function==
The primary function of IL-1β is to mediate the inflammatory response. It promotes the production of [[chemokines]] and [[adhesion molecules]], facilitating the recruitment of immune cells to sites of infection or injury. IL-1β also induces [[fever]] by acting on the hypothalamus, a process known as pyrogenesis. Furthermore, it stimulates the production of other pro-inflammatory cytokines, amplifying the inflammatory response.

In addition to its role in inflammation, IL-1β is involved in various physiological and pathological processes, including [[autoimmune diseases]], [[cancer]], and [[neurodegeneration]]. Its overproduction is associated with several inflammatory and autoimmune conditions, such as [[rheumatoid arthritis]], [[gout]], and [[type 2 diabetes]].

==Regulation==
The activity of IL-1β is tightly regulated at multiple levels, including its production, activation, and signaling. The [[interleukin-1 receptor antagonist]] (IL-1Ra) is a naturally occurring inhibitor that competes with IL-1β for binding to IL-1R, thereby blocking its pro-inflammatory effects. Therapeutic agents targeting IL-1β, such as IL-1Ra analogs and monoclonal antibodies, have been developed to treat diseases characterized by excessive IL-1β activity.

==Clinical Significance==
Given its central role in inflammation and disease, IL-1β is a target for therapeutic intervention in various conditions. Drugs that inhibit IL-1β signaling, such as Anakinra (an IL-1Ra analog), Canakinumab, and Rilonacept, have been approved for the treatment of several inflammatory diseases. These therapies have shown efficacy in reducing inflammation and improving clinical outcomes in patients with conditions driven by excessive IL-1β activity.

==Research Directions==
Research on IL-1β continues to uncover its multifaceted roles in health and disease. Studies are exploring its involvement in diseases beyond traditional inflammatory and autoimmune disorders, including psychiatric disorders and metabolic syndrome. Understanding the complex biology of IL-1β and its interactions with other components of the immune system may lead to the development of novel therapeutic strategies for a wide range of diseases.

[[Category:Cytokines]]
[[Category:Immune system]]
[[Category:Inflammation]]
{{Medicine-stub}}

Interleukin 1 beta - Revision history

Prab at 12:52, 18 March 2025

Prab: CSV import

Prab: CSV import

Prab: CSV import